2m 2m 2m 2m 2m 2m 2m
BICARA THERAP (BCAX)
NASDAQ
$28.14-$0.010 (-0.04%)
Price as of Jul 13, 2026 6:18 PM EDT- $1.9BMarket Cap
- 176.52%1-Year Change
- BiotechnologyIndustry
BICARA THERAP (BCAX)
$28.14-$0.010 (-0.04%)
BCAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.15 | ||
Change | -$0.76 (-2.63%) | ||
Open | $28.54 | ||
High | $28.54 | ||
Low | $27.57 | ||
Previous Close | $28.91 | ||
Volume | 420,317 | ||
30-Day Average Volume | 1,095,537 | ||
1-Week Change | -3.66% | ||
1-Month Change | 29.78% | ||
1-Year Change | 176.52% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 65.7M | ||
Total Assets | $553.6M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$56.2M | ||
Free Cash Flow | -$37.6M | ||
EBIT | -$56.2M | ||
EBITDA | -$56.1M | ||
Net Working Capital | $505.6M | ||
EPS | -$0.93 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -31 | ||
PEG | 0 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue